ASO Author Reflections: Chemotherapy Regimen in Borderline Resectable and Locally Advanced Pancreatic Cancer-Resection Cuts the Deal

Ann Surg Oncol. 2023 Jul;30(7):4429-4430. doi: 10.1245/s10434-023-13484-6. Epub 2023 Apr 19.

Authors

Dilmurodjon Eshmuminov¹, Botirjon Aminjonov², Russell F Palm³, Kuno Lehmann²

Affiliations

¹ Department of Surgery and Transplantation, University Hospital Zurich, University of Zurich, Zurich, Switzerland. Dilmurodjon.Eshmuminov@usz.ch.
² Department of Surgery and Transplantation, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
³ Department of Radiation Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.

No abstract available

Publication types

Comment

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Gemcitabine
Humans
Neoadjuvant Therapy
Pancreas / surgery
Pancreatectomy
Pancreatic Neoplasms* / drug therapy
Pancreatic Neoplasms* / surgery

Substances

Gemcitabine